Compugen Ltd..
publicly traded Israeli drug discovery company
- Reports this week
- 0
- Active events
- 0
- Connections
- 23
What's happening
Earlier this month
Gone quiet
No new reports in 90+ daysNo events began in the chosen period. Widen it, or reset.
Around Compugen Ltd. this week
News at the entities that move Compugen Ltd. most-
Gilead Sciences TransactionalGilead Sciences licensed a drug to manufacturers in India on November 14, 2026.Moves Compugen Ltd.
-
Ohio Shared contextA veteran wounded in combat in Iraq is involved with the U.S. Attorney’s Office in Ohio.Moves Compugen Ltd.
-
Europe Shared contextCrimea seizure fuels European instability, leading to a diplomacy summit hosted in Dublin.Moves Compugen Ltd.
-
New York City Shared contextA lawsuit was filed in New York City against Build-A-Bear Workshop on November 1, 2026.Moves Compugen Ltd.
Connections
The 7 strongest of 23, analyzed from the reporting. The bars show how strongly a change on one side reaches the other.-
AstraZeneca Structural
Compugen licenses technology and antibodies to AstraZeneca, enabling the development of the drug Rilvegostomig.
-
Gilead Sciences Transactional
Compugen licensed the drug candidate GS-0321 to Gilead for development following a partnership agreement.
-
Gilead Transactional
Compugen and Gilead engaged in multiple licensing agreements for the GS-0321 antibody.
-
Gilead Transactional
Gilead entered into a licensing agreement with Compugen Ltd. for the technology GS-0321.
-
New York City Shared context
Compugen Ltd. operates within the geographical and professional context of New York City.
-
Ohio Shared context
Compugen Ltd. is reported to research and develop candidates within the United States, a larger geographical context.
-
Europe Shared context
Compugen Ltd. conducts research and development activities within the geographical context of Europe.